Transcriptomics

Dataset Information

0

Ebola virus glycoprotein variant with increased infectivity for human cells dominated the 2013-2016 outbreak


ABSTRACT: The unprecedented magnitude of the 2013-2016 Makona Ebola virus (M-EBOV) epidemic likely resulted from multiple epidemiologic factors that set it apart from previous outbreaks. Nonetheless, genetic adaptations that distinguish M-EBOV from previous isolates may also have contributed to the scale of the epidemic. Of particular interest is a M-EBOV glycoprotein (GP) variant, GP-A82V, that was first detected at the inflection point of the 2013-2016 outbreak - when the number of cases increased exponentially - and which completely supplanted the earlier M-EBOV sequence. We found that, as compared with the earlier strain, GP-A82V increased the ability of M-EBOV to fuse with and infect cells of primate origin, including human blood dendritic cells, without altering innate immune signaling in target cells. Residue 82 is located at the NPC1-binding site on M-EBOV GP and the increased infectivity of GP-A82V was restricted to cells from species in which the NPC1 orthologue bears primate-defining residues at the critical interface. We utilized HIV-derived lentiviral vectors pseudotyped with founder and A82V containing M-EBOV GPs to explore the potential that this modification alters how human monocyte-derived dendritic cells (MDDCs) respond to EBOV GP stimulation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE84865 | GEO | 2017/08/31

SECONDARY ACCESSION(S): PRJNA335391

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2017-11-09 | GSE99463 | GEO
2016-12-31 | GSE84188 | GEO
2021-01-29 | E-MTAB-10007 | biostudies-arrayexpress
2021-07-02 | E-MTAB-10102 | biostudies-arrayexpress
2016-12-31 | GSE83309 | GEO
2018-04-12 | GSE103825 | GEO
2024-04-29 | PXD036213 | Pride
2012-04-16 | E-GEOD-36119 | biostudies-arrayexpress
2008-06-14 | E-GEOD-5944 | biostudies-arrayexpress
2023-04-02 | E-MTAB-12783 | biostudies-arrayexpress